Title : Combined inhibition of cellular pathways as a future therapeutic option in fatal anaplastic thyroid cancer.

Pub. Date : 2012 Dec

PMID : 22477151






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Caspase-3 activity was increased up to 2.7- and 14-fold by mono-application of MLN8054 and bortezomib, respectively. Bortezomib caspase 3 Homo sapiens